$RNAZ
TransCode Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.69
▼-1.74%-$0.030
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateTransCode Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is RNAZ down today? It is at $1.69 (-1.74%), and our scanner flagged it 12 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RNAZ spikes, and full due diligence on RNAZ — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RNAZ 12 times in the last 30 days. Create a free account to track $RNAZ, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on RNAZ from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RNAZ today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystExecutive / Board Change, from an SEC filing. Read it →Latest filing4Ownership documentSep 11, 2026 · 7 days agoAcross every filing on file, supply equal to at least 1496.3% of the tradeable float is in play - 1496.3% more can still be issued.
Some filings did not state a size, so these are floors.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
15,794,418 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Defj, Llc Beneficial Owner (10%) | Acquired (grant/award) | +13.83M 1307.0% of company | added 100% | 14.13M | n/a | Aug 3, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on RNAZ from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RNAZ today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
RNAZ last traded at $1.69, down 1.74% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The RNAZ Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RNAZ 12 times in the last 30 days.
RNAZ (TransCode Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $2M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RNAZ for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RNAZ discussion
Sign in to ask a question or join the discussion.